Breast Cancer Incidence, 1980 2006: Combined Roles of Menopausal Hormone Therapy, Screening Mammography, and Estrogen Receptor Status
The DOI matches its Crossref record; 31 of the 31 references it cites were found in a registry or an index.
Abstract
BACKGROUND: Breast cancer incidence has been rising since at least 1935-1939, but recent US data reveal a statistically significant decline in breast cancer incidence in 2003 that persisted through 2004. Identifying the specific contributions of the potential causes of this long-term increase and the recent decrease in incidence has been challenging. Marked changes in rates of mammography screening and use of menopausal hormone therapy since 1980 have added further complexity. We examined the potential association between menopausal hormone therapy use and recent changes in breast cancer incidence. METHODS: Using tumor registry, clinical, pathology, and pharmacy data from Kaiser Permanente Northwest, a large prepaid US health plan, we compared age-specific and age-adjusted breast cancer incidence rates (2-year moving averages) with use of screening mammography and dispensed menopausal hormone therapy prescriptions between 1980 and 2006. Temporal changes in incidence rates were assessed via joinpoint regression. RESULTS: A total of 7386 incident invasive breast cancers were diagnosed in plan members from 1980 through 2006. Overall age-adjusted breast cancer incidence rates per 100,000 women rose 25% from the early 1980s (105.6) to 1992-1993 (131.7) and an additional 15% through 2000-2001 (151.3), then dropped by 18% to 2003-2004 (123.6) and edged up slightly in 2005-2006 (126.2). These patterns were largely restricted to women aged 45 years or older and to estrogen receptor-positive (ER+) breast cancers. Incidence rates of ER-negative tumors experienced neither of the rises seen for ER+ tumors but also fell precipitously from 2003 through 2006. Rates of mammography screening sharply increased from 1980 to 1993 but then leveled off, and 75%-79% of women aged 45 years or older received a mammogram at least once every 2 years from 1993 through 2006. Menopausal hormone therapy dispensings, particularly of estrogen-plus-progestin formulations, increased from 1988 to 2002 but then dropped by approximately 75% after 2002. CONCLUSIONS: From 1980 through 2006, quantitative and qualitative trends in breast cancer incidence rates, particularly for ER+ tumors, parallel major changes in patterns of mammography screening and use of menopausal hormone therapy.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Writing Group for the Women's Health Initiative Investigators (2002) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.288.3.321 · Cited by 15,889
Permutation tests for joinpoint regression with applications to cancer rates
Kim, H.-J., Fay, M. P., Feuer, E. J., & Midthune, D. N. (2000) · Statistics in Medicine · doi:10.1002/(sici)1097-0258(20000215)19:3<335::aid-sim336>3.0.co;2-z · Cited by 6,318
Hulley, S. (1998) · JAMA · doi:10.1001/jama.280.7.605 · Cited by 6,216
Breast cancer and hormone-replacement therapy in the Million Women Study
(2003) · The Lancet · doi:10.1016/s0140-6736(03)14065-2 · Cited by 2,993
Effect of Screening and Adjuvant Therapy on Mortality from Breast Cancer
Berry, D. A., Cronin, K. A., Plevritis, S. K., Fryback, D. G., Clarke, L., Zelen, M., Mandelblatt, J. S., Yakovlev, A. Y., Habbema, J. D. F., & Feuer, E. J. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa050518 · Cited by 2,460
National Use of Postmenopausal Hormone Therapy: Annual Trends and Response to Recent Evidence
Hersh, A. L., Stefanick, M. L., & Stafford, R. S. (2004) · JAMA · doi:10.1001/jama.291.1.47 · Cited by 983
The Decrease in Breast-Cancer Incidence in 2003 in the United States
Ravdin, P. M., Cronin, K. A., Howlader, N., Berg, C. D., Chlebowski, R. T., Feuer, E. J., Edwards, B. K., & Berry, D. A. (2007) · New England Journal of Medicine · doi:10.1056/nejmsr070105 · Cited by 982
Kim, H. (2001) · Statistics in Medicine · doi:10.1002/sim.811 · Cited by 873
Anderson, W. F., Chatterjee, N., Ershler, W. B., & Brawley, O. W. (2002) · Breast Cancer Research and Treatment · doi:10.1023/a:1020299707510 · Cited by 585
Periodic Breast Cancer Screening in Reducing Mortality From Breast Cancer
Shapiro, S. (1971) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1971.03180240027005 · Cited by 499
Howe, H. L., Wu, X., Ries, L. A. G., Cokkinides, V., Ahmed, F., Jemal, A., Miller, B., Williams, M., Ward, E., Wingo, P. A., et al. (2006) · Cancer · doi:10.1002/cncr.22193 · Cited by 427
Effect of Screening and Adjuvant Therapy on Mortality From Breast Cancer
Berry, D. A., Cronin, K. A., Plevritis, S., Fryback, D. G., Clarke, L., Zelen, M., Mandelblatt, J. S., Yakovlev, A. Y., Habbema, J. D. F., & Feuer, E. (2006) · Obstetrical & Gynecological Survey · doi:10.1097/01.ogx.0000201966.23445.91 · Cited by 386
Recent trends in breast cancer incidence rates by age and tumor characteristics among U.S. women
Jemal, A., Ward, E., & Thun, M. J. (2007) · Breast Cancer Research · doi:10.1186/bcr1672 · Cited by 351
Zackrisson, S., Andersson, I., Janzon, L., Manjer, J., & Garne, J. P. (2006) · BMJ · doi:10.1136/bmj.38764.572569.7c · Cited by 341
Changes in the Use of Postmenopausal Hormone Therapy after the Publication of Clinical Trial Results
Haas, J. S., Kaplan, C. P., Gerstenberger, E. P., & Kerlikowske, K. (2004) · Annals of Internal Medicine · doi:10.7326/0003-4819-140-3-200402030-00009 · Cited by 314
Porter, P. L., El-Bastawissi, A. Y., Mandelson, M. T., Lin, M. G., Khalid, N., Watney, E. A., Cousens, L., White, D., Taplin, S., & White, E. (1999) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/91.23.2020 · Cited by 264
Stefanick, M. L. (2005) · The American Journal of Medicine · doi:10.1016/j.amjmed.2005.09.059 · Cited by 212
Reported drop in mammography: Is this cause for concern?
Breen, N., A. Cronin, K., Meissner, H. I., Taplin, S. H., Tangka, F. K., Tiro, J. A., & McNeel, T. S. (2007) · Cancer · doi:10.1002/cncr.22723 · Cited by 198
Building a Research Consortium of Large Health Systems: The Cancer Research Network
Wagner, E. H. (2005) · Journal of the National Cancer Institute Monographs · doi:10.1093/jncimonographs/lgi032 · Cited by 179
Breast screening, prognostic factors and survival – results from the Swedish two county study
Duffy, S., Tabar, L., Fagerberg, G., Gad, A., Gröntoft, O., South, M., & Day, N. (1991) · British Journal of Cancer · doi:10.1038/bjc.1991.477 · Cited by 174
Promotion and Prescribing of Hormone Therapy After Report of Harm by the Women’s Health Initiative
Majumdar, S. R. (2004) · JAMA · doi:10.1001/jama.292.16.1983 · Cited by 172
Clarke, C. A., Glaser, S. L., Uratsu, C. S., Selby, J. V., Kushi, L. H., & Herrinton, L. J. (2006) · Journal of Clinical Oncology · doi:10.1200/jco.2006.08.6504 · Cited by 160
Graphical Presentation of Trends in Rates
Devesa, S. S., Donaldson, J., & Fears, T. (1995) · American Journal of Epidemiology · doi:10.1093/aje/141.4.300 · Cited by 159
Kerlikowske, K. M., Miglioretti, D. L., Buist, D. S. M., Walker, R. L., & Carney, P. A. (2007) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djm111 · Cited by 156
Chen, W. Y., Hankinson, S. E., Schnitt, S. J., ROSNER, B. A., Holmes, M. D., & Colditz, G. A. (2004) · Cancer · doi:10.1002/cncr.20499 · Cited by 142
Breast Cancer Risk and Duration of Estrogen Use
STEINBERG, K. K., Smith, S. J., Thacker, S. B., & Stroup, D. F. (1994) · Epidemiology · doi:10.1097/00001648-199407000-00007 · Cited by 98
Rising Incidence of Breast Cancer: Relationship to Stage and Receptor Status
Glass, A. G., & Hoover, R. N. (1990) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/82.8.693 · Cited by 87
Self-citationAnderson, W. F., Jatoi, I., & Devesa, S. S. (2006) · Breast Cancer Research and Treatment · doi:10.1007/s10549-006-9214-z · Cited by 83
Estrogen-progestin replacement and risk of breast cancer
Schairer, Lubin, Troisi, Sturgeon, Brinton, & Hoover, R. (2000) · PubMed · Cited by 51
Self-citationCorrelates of hormone replacement therapy use in Italian women, 1992–1996
Chiaffarino, F., Parazzini, F., Vecchia, C. L., Bianchi, M., Benzi, G., Ricci, E. D., & Chiàntera, V. (1999) · Maturitas · doi:10.1016/s0378-5122(99)00055-9 · Cited by 32
Cited by
Sung, H., Ferlay, J., Siegel, R. L., Laversanne, M., Soerjomataram, I., Jemal, A., & Bray, F. (2021) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21660 · Cited by 108,699
Current and future burden of breast cancer: Global statistics for 2020 and 2040
Arnold, M., Morgan, E., Rumgay, H., Mafra, A., Singh, D., Laversanne, M., Vignat, J., Gralow, J. R., Cardoso, F., Siesling, S., et al. (2022) · The Breast · doi:10.1016/j.breast.2022.08.010 · Cited by 3,411
Global patterns of cancer incidence and mortality rates and trends
Jemal, A., Center, M. M., DeSantis, C., & Ward, E. M. (2010) · Cancer Epidemiology, Biomarkers & Prevention · doi:10.1158/1055-9965.epi-10-0437 · Cited by 2,778
Breast cancer statistics, 2013
DeSantis, C., Ma, J., Bryan, L., & Jemal, A. (2014) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21203 · Cited by 2,143
Ma, J., & Jemal, A. (2013) · Breast Cancer Metastasis and Drug Resistance · doi:10.1007/978-1-4614-5647-6_1 · Cited by 1,907
Metadata
- Authors
- Glass, A. G., Lacey, J. V., Carreon, J. D., & Hoover, R. N.
- Venue
- JNCI Journal of the National Cancer Institute
- Publisher
- Oxford University Press (OUP)
- Published
- 2007-07-24
- Volume
- 99
- Issue
- 15
- Pages
- 1152-1161
- ISSN
- 0027-8874 (ISSN-L)
- 1460-2105
- OpenAlex
- W2165686484
- Cited by
- 439
- References
- 31
- FWCI
- 24.00
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.